Not Yet RecruitingNot Applicable

Application to Predict Neonatal Apnea With Bradycardia

United States25 participantsStarted 2026-07-01

Plain-language summary

This purpose of this study is to reduce or stop apneas and bradycardias in pre-term infants, before they occur using gentle stimulation.

Who can participate

Age range22 Weeks – 32 Weeks

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Documented episodes of apnea with bradycardia over the previous 24 hours. * Off ventilatory support/NCPAP for \> 48 hours prior to study entry * Gestational age \< 32 0/7 weeks' gestation at birth * Parents/legal guardians have provided consent for enrollment Exclusion Criteria: * a major malformation or a neuromuscular condition that affects respiration or causes apnea, or terminal illness or decision to withhold or limit support.

What they're measuring

Bradycardia <100 beats per minute ≥ 10 seconds

Timeframe: 4-hours on either intervention.

Trial details

NCT IDNCT06852053

SponsorUniversity of Alabama at Birmingham

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2026-12-31

Contact for this trial

Rachel L. Benz, Clinical Research Nurse Manager, MSN

205-934-2184 rlbenz@uabmc.edu

View on ClinicalTrials.gov More Apnea Neonatal trials